Get the Stockscreener App
1.99
9.95%
-0.22
After Hours:
1.90
-0.09
-4.52%
Mereo Biopharma Group Plc Adr Stock (MREO) Forecast
The Mereo Biopharma Group Plc Adr (MREO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.922, representing a -53.67% decrease from the current price of $1.99. The highest analyst price target is $1.0318, and the lowest is $0.8121.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MREO Price Target
Average 1.4035
(-29.47% Downside)
Is Mereo Biopharma Group Plc Adr (MREO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.90 | Neutral |
| STOCH(9,6) | 17.65 | Buy |
| STOCHRSI(14) | 41.08 | Neutral |
| MACD(12,26) | -0.1387 | Sell |
| ADX(14) | 25.16 | Sell |
| William %R | -92.50 | Buy |
| CCI(14) | -161.32 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.291
Sell
|
2.2685
Sell
|
| MA20 |
2.4105
Sell
|
2.3768
Sell
|
| MA50 |
2.6458
Sell
|
2.6471
Sell
|
| MA100 |
3.0974
Sell
|
2.991
Sell
|
| MA200 |
3.6218
Sell
|
3.2154
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MREO could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on MREO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.9 indicates that MREO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.65 indicates that MREO is oversold. This indicates that MREO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 41.08 indicates that MREO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.16 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -161.32 indicates that MREO is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MREO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Mereo Biopharma Group Plc Adr financial reports and earnings history, Mereo Biopharma Group Plc Adr (MREO) stock could reach $1.0265 by 2030, $3.6904 by 2040 and $7.4745 by 2050. See the projected annual prices until 2050 of the Mereo Biopharma Group Plc Adr stock below:
- Mereo Biopharma Group Plc Adr (MREO) is expected to reach an average price of $0.6697 in 2035, with a high prediction of $0.8205 and a low estimate of $0.7897. This indicates an $-66.35% rise from the last recorded price of $1.99.
- Mereo Biopharma Group Plc Adr (MREO) stock is projected to chart a bullish course in 2040, with an average price target of $3.2493, representing an $63.28% surge from its current level. The forecast ranges from a conservative $3.5993 to a sky-high $3.6904.
- Our analysts predict Mereo Biopharma Group Plc Adr (MREO) to jump 178.55% by 2045, soaring from $5.5347 to an average price of $5.5432, potentially reaching $5.6089. While $5.5347 is the low estimate, the potential upside is significant.
- Mereo Biopharma Group Plc Adr (MREO) stock is expected to climb by 2050, reaching an average of $7.336, a $268.64% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.4745 and $7.466, respectively, highlighting the market's uncertainty.
Mereo Biopharma Group Plc Adr Stock (MREO) Year by Year Forecast
Mereo Biopharma Group Plc Adr Stock (MREO) Price Forecast for 2025
Mereo Biopharma Group Plc Adr Stock (MREO) is expected to reach an average price of $1.1157 in 2025, with a high prediction of $2.187 and a low estimate of $0.0444. This indicates an -43.94% fall from the last recorded price of $1.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.7721 | $0.8121 | $1.0318 | -61.20% |
| June, 2025 | $0.7392 | $0.8889 | $0.7189 | -62.85% |
| July, 2025 | $1.317 | $0.2737 | $2.187 | -33.82% |
| August, 2025 | $0.9299 | $0.7599 | $1.6402 | -53.27% |
| September, 2025 | $0.7828 | $0.4796 | $1.393 | -60.66% |
| October, 2025 | $0.719 | $0.5661 | $1.3225 | -63.87% |
| November, 2025 | $0.6119 | $0.4323 | $1.0855 | -69.25% |
| December, 2025 | $0.3781 | $0.0684 | $0.6849 | -81.00% |
Mereo Biopharma Group Plc Adr Stock (MREO) Price Forecast for 2026
The predicted value for Mereo Biopharma Group Plc Adr (MREO) in 2026 is set at an average of $1.4107. Estimates vary from a peak of $2.7775 to a trough of $0.044, indicating an -29.11% surge from the present price of $1.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.456 | $0.2646 | $0.5813 | -77.08% |
| February, 2026 | $1.5735 | $0.044 | $2.284 | -20.93% |
| March, 2026 | $1.3669 | $1.2273 | $1.8104 | -31.31% |
| April, 2026 | $2.4631 | $0.6534 | $2.7631 | +23.77% |
| May, 2026 | $2.086 | $1.3995 | $2.7775 | +4.82% |
| June, 2026 | $2.1689 | $1.2425 | $2.4592 | +8.99% |
| July, 2026 | $1.2051 | $0.8751 | $2.2322 | -39.44% |
| August, 2026 | $1.298 | $1.0383 | $1.8648 | -34.77% |
| September, 2026 | $1.1342 | $0.8942 | $1.7013 | -43.00% |
| October, 2026 | $0.8472 | $0.5439 | $1.1507 | -57.43% |
| November, 2026 | $0.9501 | $0.2586 | $1.0904 | -52.26% |
| December, 2026 | $0.6163 | $0.4663 | $1.0933 | -69.03% |
Mereo Biopharma Group Plc Adr Stock (MREO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Mereo Biopharma Group Plc Adr (MREO) is $0.5899, with a high forecast of $1.1476 and a low forecast of $0.0322. This indicates an -70.36% decrease from the last price of $1.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3392 | $0.2692 | $0.7728 | -82.96% |
| February, 2027 | $0.2121 | $0.0322 | $0.6989 | -89.34% |
| March, 2027 | $0.0717 | $0.0646 | $0.2654 | -96.40% |
| April, 2027 | $0.3388 | $0.2085 | $0.3188 | -82.98% |
| May, 2027 | $0.5258 | $0.5758 | $0.4923 | -73.58% |
| June, 2027 | $0.5897 | $0.5897 | $0.5029 | -70.37% |
| July, 2027 | $0.6067 | $0.5332 | $0.3732 | -69.51% |
| August, 2027 | $0.9738 | $0.6635 | $0.7538 | -51.07% |
| September, 2027 | $1.1766 | $1.1206 | $1.1476 | -40.87% |
| October, 2027 | $0.3847 | $1.1246 | $1.1444 | -80.67% |
| November, 2027 | $0.3018 | $0.4268 | $0.275 | -84.84% |
| December, 2027 | $0.3056 | $0.1852 | $0.3588 | -84.64% |
Mereo Biopharma Group Plc Adr Stock (MREO) Price Forecast for 2028
In 2028, Mereo Biopharma Group Plc Adr (MREO) is projected to reach an average price of $0.5525, with a high projection of $0.8843 and a low estimate of $0.2207. This indicates an -72.24% fall from the last price of $1.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5727 | $0.4759 | $0.4827 | -71.22% |
| February, 2028 | $0.7686 | $0.6262 | $0.7197 | -61.38% |
| March, 2028 | $0.6137 | $0.6636 | $0.6036 | -69.16% |
| April, 2028 | $0.8334 | $0.8293 | $0.7806 | -58.12% |
| May, 2028 | $1.0838 | $0.8208 | $0.8843 | -45.54% |
| June, 2028 | $0.6015 | $0.7447 | $0.8078 | -69.77% |
| July, 2028 | $0.5745 | $0.6318 | $0.545 | -71.13% |
| August, 2028 | $0.7624 | $0.5753 | $0.599 | -61.69% |
| September, 2028 | $0.6412 | $0.7959 | $0.6927 | -67.78% |
| October, 2028 | $0.3165 | $0.3765 | $0.4762 | -84.09% |
| November, 2028 | $0.4404 | $0.3901 | $0.4236 | -77.87% |
| December, 2028 | $0.1674 | $0.2207 | $0.1374 | -91.59% |
Mereo Biopharma Group Plc Adr Stock (MREO) Price Forecast for 2029
The 2029 price forecast for Mereo Biopharma Group Plc Adr Stock (MREO) is $1.5115 on average, with a high prediction of $2.9922 and a low estimate of $0.0308. This represents an -24.05% decrease from the previous price of $1.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1413 | $0.241 | $0.1745 | -92.90% |
| February, 2029 | $0.1417 | $0.2383 | $0.1717 | -92.88% |
| March, 2029 | $0.1146 | $0.0986 | $0.3149 | -94.24% |
| April, 2029 | $0.1425 | $0.1222 | $0.2378 | -92.84% |
| May, 2029 | $0.6637 | $0.0308 | $0.9737 | -66.65% |
| June, 2029 | $0.8166 | $0.4534 | $0.9502 | -58.96% |
| July, 2029 | $0.9196 | $0.5499 | $1.0596 | -53.79% |
| August, 2029 | $2.4157 | $0.8428 | $2.8025 | +21.39% |
| September, 2029 | $2.3187 | $2.0687 | $2.9922 | +16.52% |
| October, 2029 | $1.6348 | $1.5138 | $2.7151 | -17.85% |
| November, 2029 | $1.3078 | $1.1928 | $2.1413 | -34.28% |
| December, 2029 | $0.88 | $0.13 | $1.8975 | -55.78% |
Mereo Biopharma Group Plc Adr Stock (MREO) Price Forecast for 2030
Mereo Biopharma Group Plc Adr Stock (MREO) is expected to reach an average price of $1.6936 in 2030, with a high forecast of $3.1402 and a low forecast of $0.2471. This signifies an -14.89% decrease from the last price of $1.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.1177 | $0.2471 | $1.0265 | -43.84% |
| February, 2030 | $2.2618 | $1.6582 | $1.7918 | +13.66% |
| March, 2030 | $1.5559 | $1.8459 | $1.6189 | -21.81% |
| April, 2030 | $0.7601 | $0.8365 | $1.5495 | -61.81% |
| May, 2030 | $1.4177 | $1.2171 | $1.3977 | -28.76% |
| June, 2030 | $1.0718 | $1.1418 | $1.0812 | -46.14% |
| July, 2030 | $2.2395 | $1.4754 | $1.7811 | +12.54% |
| August, 2030 | $3.0636 | $2.2466 | $2.7836 | +53.95% |
| September, 2030 | $2.1932 | $1.7742 | $1.4178 | +10.21% |
| October, 2030 | $2.5754 | $2.185 | $2.3819 | +29.42% |
| November, 2030 | $3.1496 | $2.5725 | $2.2496 | +58.27% |
| December, 2030 | $3.1937 | $3.2537 | $3.1402 | +60.49% |
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):